Skip to main content

ESMO World Congress on Gastrointestinal Cancer Main banner

Session V: Presentation of Selected Non-Colorectal Cancer Abstracts

SO-8: Soluble programmed cell death ligand 1 associated with clinical outcome in gastric cancer patients treated with nivolumab: Blood based biomarker analysis of DELIVER trial (JACCRO-GC08AR)

Thursday, June 30, 2022

09:06 – 09:14

Location: Auditorium B; Level 0

Abstract Presenter(s)

HK

Hisato Kawakami